◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY
Nipro Corporation (8086)
来自官方财务报表的收入、利润与现金流历史。
Healthcare · 华尔街（美国） · 最近更新： 2026-10-02
Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc.
关键数据
- 市值: JPY 213 billion
- 收入（截至 2026-03-31 财年）: JPY 660.5B
- 净利润: JPY 13.5B
- 毛利率: 31.5%
- 净利率: 2.0%
查看交互式图表与完整报表 →
估值模型 (DCF) →
年度利润表
| 利润表 | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|
| 总收入 | JPY 660.5B | JPY 644.6B | JPY 586.8B | JPY 545.2B | — |
| 毛利 | JPY 208.3B | JPY 190.9B | JPY 171.3B | JPY 163.4B | — |
| 营业利润（EBIT） | JPY 37.6B | JPY 26.6B | JPY 22.3B | JPY 17.7B | — |
| 净利 | JPY 13.5B | JPY 5.1B | JPY 11.1B | JPY 4.6B | — |
来源：公司公开报告（SEC）。在依赖任何数字前请核对 SEC EDGAR。
资产负债表、现金流、季度数据与完整财务比率见 8086 交互式查看器。 /companies/us/8086
类似公司
本网站信息仅用于教育与参考，不构成投资建议。不发布目标价或买卖建议。
About TickerBase · Data methodology & sources · Privacy · Terms
TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.